// App-Quantinova.ai

TCT-226 : Application of the Academic Research Consortium High Bleeding Risk Trade-Off Model in an All-Comers Global Registry of Percutaneous Coronary Intervention

Researchers

Presenter

  • Shoichi Kuramitsu

Principal Investigators

  • Davide Capodanno

  • Mamas Mamas

  • Marie-Claude Morice

Medical Centers

  • Kokura memorial hospital, Kitakyusyu, Japan

  • Royal Stoke Hospital, Stoke-On-Trent, United Kingdom

  • Azienda Ospedaliero-Universitaria “Policlinico-Vittorio Emanuele,” Catania, Italy

  • Cardiovascular European Research Center, Massy, France

Locations

  • Japan

  • Italy

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved